| (GBp) | Jun 2015 | Y/Y change |
|---|---|---|
| Revenue | 4.38M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, OXB.L returned -3.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -14.7% |
| 1 year | -3.0% |
| 5 years | -65.7% |
| 10 years | +142.4% |
| All-time high | GBX 5,252.33 (Feb 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what £1,000 in OXB.L would be worth today ›No. Oxford Biomedica plc has not paid a dividend in the past 12 months.
Oxford Biomedica plc is part of the Healthcare sector.
Oxford Biomedica plc has a market cap of 616.12M GBp, based on the latest quote.
Oxford Biomedica plc is expected to report earnings around Sep 23, 2026. That date is an estimate and has not been confirmed by the company.
